Differentiation therapy for solid tumors
- 16 March 2014
- journal article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 15 (4), 159-165
- https://doi.org/10.1111/1751-2980.12122
Abstract
Differentiation therapy for tumors refers to treating malignant tumors via the induction of cell differentiation. The best characterized clinical application of differentiation therapy is the use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia (APL), which markedly improved the outcome of this disease. Unlike the situation with APL, the development of differentiation therapy for solid tumors is far from satisfactory. To date, no differentiation-inducing agents have been demonstrated to exert a curative effect on solid tumors. However, over the past decade progress in understanding the differentiation pathways and the development of differentiation-inducing agents might shed new light on the differentiation therapy for solid tumors.Keywords
This publication has 58 references indexed in Scilit:
- Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapyJournal of Translational Medicine, 2011
- An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular OncogenesisCell, 2011
- NOTCH Signaling and ATOH1 in Colorectal CancersCurrent Colorectal Cancer Reports, 2011
- The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer cellsCell Death & Differentiation, 2011
- Transcription factor-based modulation of neural stem cell differentiation using direct protein transductionCellular and Molecular Life Sciences, 2010
- Differentiation therapy of leukemia: 3 decades of developmentBlood, 2009
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cellsHepatology, 2009
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cellsBMC Medicine, 2008
- High-Throughput Screening Assay for the Identification of Compounds Regulating Self-Renewal and Differentiation in Human Embryonic Stem CellsCell Stem Cell, 2008
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004